sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group's Latest Disclosure on Spire Healthcare
The Vanguard Group, Inc. has released a Form 8.3 disclosure concerning its interests in Spire Healthcare Group plc, detailing its involvement in relevant securities. As of June 8, 2026, Vanguard owns 14,479,362 ordinary shares, representing a 3.60% stake in Spire Healthcare.
Additionally, the disclosure reports a recent sale of 2,850 ordinary shares at a price of 2.17 GBP each. No cash-settled or stock-settled derivatives are noted in the current position.
The filing states there are no indemnity or other dealing arrangements, nor agreements concerning securities voting rights or future acquisitions. Furthermore, no Supplemental Form 8 (Open Positions) is attached to the disclosure.
The disclosure was submitted by Shawn Acker on June 9, 2026. No other parties to the Spire Healthcare offer are disclosed in this filing.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.